The Uromigos

Episode 137: ESMO 2021: PEACE1 overall survival in prostate cancer 19.09.2021 24:38 ↓

Karim Fizazi describes the OS benefit of the triplet. 

Episode 136: ESMO 2021: STAMPEDE Abiraterone for high-risk non-metastatic prostate cancer 19.09.2021 18:55 ↓

Gert Attard describes this practice-changing plenary data. 

Episode 135: ESMO 2021: The STAR Study 19.09.2021 31:48 ↓

Intermittent VEGF TKI vs continuous phase 3 trial by Janet Brown.

Episode 134: ESMO 2021: The PRISM Study 19.09.2021 24:11 ↓

Naveen Vasudev describes a three-monthly IPI dosing with Nivo in mRCC.

Episode 133: ESMO 2021: Cabozantinib and atezolizumab in prostate cancer 18.09.2021 27:55 ↓

Neeraj Agarwal describes the phase 2 study and the phase 3 plans. 

Episode 132: ESMO 2021: Pembro + sEphB4-HAS in bladder cancer 17.09.2021 11:47 ↓

Sarmad Sadeghi describes the above study at ESMO 2021. 

Episode 131: ESMO 2021: The NORSE Study - Erdafitinib vs Erdafitinib/Cetrelimab 17.09.2021 22:44 ↓

Jonathan Rosenberg gives an overview. 

Episode 130: Larry Einhorn - The Uromigos Legends in GU Cancer series 06.09.2021 33:37 ↓

Larry Einhorn describes the spectacular advances in testis cancer. 

Episode 129: Phil Kantoff - The Uromigos Legends in GU Cancer series 02.09.2021 31:15 ↓

Phil discusses his career progression and prostate cancer. 

Episode 128: APCCC - PSA relapse post prostatectomy 31.08.2021 26:12 ↓

Neha Vapiwala discusses investigations and treatment for these patients. 

Episode 127: APCCC - Adjuvant radiotherapy post prostatectomy 31.08.2021 28:02 ↓

Alberto Bossi discusses the role of adjuvant therapy. 

Episode 126: APCCC - germ line testing and molecular testing in prostate cancer 31.08.2021 21:50 ↓

Ros Eeles gives a clinically focused overview of this topic. 

Episode 125: The Uromigos Paper of the Month - MRI screening for prostate cancer 27.08.2021 28:10 ↓

Martin Ekland discusses his NEJM and Lancet Oncology papers. 

Episode 124: Dean Bajorin - The Uromigos Legends in GU Cancer series 23.08.2021 33:29 ↓

Dean Bajorin discusses developments in bladder and collaboration in testis cancer. 

Episode 123: Maha Hussain - The Uromigos Legends in GU Cancer series 20.08.2021 30:17 ↓

Maha discusses her career in GU cancer with a focus on prostate cancer. 

Episode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer series 16.08.2021 32:22 ↓

Nick discusses his career and describes treatment advances in RCC. 

Episode 121: Conflicts of Interest with the podcasts 04.08.2021 16:48 ↓

Tom, Brian and Chris discuss developments for Uromigos podcasts and growth for the future. 

Episode 119: EAU - Surgery in urothelial cancer 23.07.2021 24:20 ↓

Ashish Kamat walks through ongoing issues at EAU.

Episode 118: Prostate cancer highlights at EAU 20.07.2021 20:37 ↓

Peter Albers discusses three timely prostate cancer topics from the recent EAU meeting.

Episode 117: PD1/VEGF adverse event management in renal cancer 20.07.2021 27:29 ↓

Betsy Plimack discusses the tricks of the trade. 

Episode 116: Renal cancer surgery controversies at EAU 14.07.2021 22:51 ↓

Grant Stewart gives his opinion on timely RCC surgical topics surrounding the European Association of Urology meeting 

Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population 05.07.2021 20:52 ↓

Kosj Yamoah (Moffitt Cancer Center) describes the work he presented at ASCO 2021. 

Episode 115: Triplet therapy for 1st line metastatic prostate cancer 01.07.2021 23:20 ↓

Eric Small is quizzed about this topic. Tom gets confused between York and Leeds. 

Episode 114: Radionucleotides in prostate cancer 18.06.2021 18:56 ↓

Chris Sweeney and Silke Gillessen give their opinion of recent data. 

Episode 113: ASCO 2021 Enazlutamide +/- Radium-223 18.06.2021 11:03 ↓

Silke Gillessen gives a safety update from this EORTC study focusing on fractures.